StockData
Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc. (PBSV) stock

PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 9/30
$0.48+0.08 (+20.00%)

Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –

Pharma-Bio Serv pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Pharma-Bio Serv's pe ratio was 48.0× on Oct 19, 2026, against 26.4× a year earlier. Over the last 5 years it ranged from 3.5× to 285.0×, with a median of 16.9×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 202648.0×+14.7
2025Aug 29, 202533.3×+8.3
2024May 31, 202425.0×+6.6
2023Dec 29, 202318.4×+10.7
2021Nov 30, 20217.8×−8.5
2020Dec 31, 202016.3×+6.6
2019Dec 31, 20199.7×−9.9
2018Dec 31, 201819.6×−8.5
2016Nov 30, 201628.1×+13.6
2015Dec 31, 201514.5×+1.7
2014Dec 31, 201412.7×+2.7
2013Dec 31, 201310.0×+6.4
2012Dec 31, 20123.7×−1.3
2011Dec 30, 20115.0×−10.3
2010Dec 31, 201015.3×–

More Pharma-Bio Serv figures

See a number that looks wrong?